Auna Posts 19% Revenue Growth but Cuts 2026 EBITDA Outlook as Profit Halves
AUNA sits 17% above its 52-week low of $4.09.
Summary
Auna delivered 3Q26 revenue of S/1,325M, up 19% as reported and 10% FX-neutral, but adjusted EBITDA of S/231M was flat as reported and down 5% FX-neutral — growth is not converting into earnings. Net income fell to S/24M from S/53M a year ago, though the prior-year period carried a S/40M non-cash FX gain. The company now guides 2026 adjusted EBITDA to be broadly stable or slightly down year over year, a touch softer than the roughly flat framing given on October 22, while reaffirming 10%-14% FX-neutral revenue growth. Colombia and Peru profitability are the drag; cash flow is the bright spot at S/713M year-to-date, up 62%, helped by lower tax payments.
At the time of this announcement, AUNA was trading at $4.77 on NYSE in the Life Sciences sector, with a market capitalization of approximately $353M. The 52-week trading range was $4.09 to $6.29. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.